Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CONTINUUM-HF in acute decompensated congestive heart failure
ACTRN12613001060730Phase 2Terminated
- Sponsor
- South Australian Health and Medical Research Institute
- Start
- Aug 2014
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of human pro-ANP (31-67) in heart failure (HF) (3 arms), sponsored by South Australian Health and Medical Research Institute. Primary endpoint: Change in creatinine clearance from baseline to 72 hours. Started Aug 2014; status: terminated.
02
Drugs
human pro-ANP (31-67)
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on ACTRN12613001060730.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12613001060730.